# Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia

> **NCT03055624** · NA · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 9 (actual)

## Conditions studied

- Prostatic Hyperplasia, Benign
- Enlarged Prostate With Lower Urinary Tract Symptoms

## Interventions

- **DEVICE:** Embosphere microparticles for prostate artery embolization

## Key facts

- **NCT ID:** NCT03055624
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2019-02-18
- **Final completion:** 2019-02-18
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2020-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03055624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03055624, "Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03055624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
